guanabenz has been researched along with Toxoplasmosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Martynowicz, J; Sullivan, WJ | 1 |
| Abdelhamid Elgendy, WM; El Marhoumy, SM; El-Kowrany, SI; El-Nouby, KA; Haggag, YA | 1 |
| Konrad, C; Queener, SF; Sullivan, WJ; Wek, RC | 1 |
3 other study(ies) available for guanabenz and Toxoplasmosis
| Article | Year |
|---|---|
Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis.
Topics: Animals; Guanabenz; Mice; Mice, Inbred BALB C; Recurrence; Toxoplasma; Toxoplasmosis | 2021 |
Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
Topics: Animals; Guanabenz; Mice; Nanoparticles; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis | 2023 |
Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.
Topics: Animals; Cinnamates; Eukaryotic Initiation Factor-2; Guanabenz; Mice; Mice, Inbred BALB C; Phosphorylation; Thiourea; Toxoplasma; Toxoplasmosis | 2013 |